Neurocrine Biosciences Inc at Barclays Global Healthcare Conference Transcript
All right. Good afternoon, and welcome to the Barclays Global Healthcare Conference. My name is Carter Gould, Senior biopharma analyst here at Barclays. Pleased to welcome Neurocrine Biosciences to the stage.
We have Kevin Gorman, CEO; Matt Abernethy, CFO. Kevin, Matt, thanks very much for joining us here today. Really glad we could meet in person finally after a long period. We are overweight, Neurocrine, and very glad to have you guys today.
Thank you very much, Carter, and thanks to Barclays for the invitation here. Really looking forward to -- good to see a lot of familiar faces. Before you start grilling me, I just wanted to say that we are going to be making forward-looking statements. So I would encourage you to look at our recent SEC filings.
Okay. And maybe, I might ask you just make a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |